Home›Stock Screener›Epigral›Financial Statements

Epigral Complete Financial Statements

5 Years of Data
2025 - 2021

In FY2025, Epigral (EPIGRAL) reported revenue ₹589 Cr, net profit ₹51 Cr and EPS ₹11.87, with a net profit margin of 8.7% and ROE of 2.7%. Full financial statements from FY2021 to FY2025 (5 years) — income statement, balance sheet and cash flow in ₹ Crores. Download as Excel or CSV. Explore EPIGRAL intrinsic value to estimate fundamental worth using multiple valuation models.

Complete Financial Data Export

Profitability Ratios

Net Profit Margin 8.66% 2025 data
EBITDA Margin 22.75% 2025 data
Operating Margin 22.00% 2025 data
Return on Assets 1.62% 2025 data
Return on Equity 2.68% 2025 data

Balance Sheet Ratios

Current Ratio 1.03 2025 data
Equity Ratio 60.44% 2025 data
Asset Turnover 0.19 2025 data

EPIGRAL Revenue, Net Profit & EBITDA — Year-on-Year Growth

EPIGRAL YoY (Sept 2024 vs Sept 2025) — revenue -6.8%, net profit -37.0%, EBITDA -27.6%, expenses +1.6%. For live price, earnings ratios and company overview, see Epigral share price chart.

Revenue Growth
-6.8%
Year-over-Year
Net Profit Growth
-37.0%
Year-over-Year
EBITDA Growth
-27.6%
Year-over-Year
Expense Growth
+1.6%
Year-over-Year
Assets Growth
+12.8%
Year-over-Year
Equity Growth
+51.9%
Year-over-Year
Operating Cash Flow Growth
-36.4%
Year-over-Year
Investing Cash Flow Growth
+8.2%
Year-over-Year
Financing Cash Flow Growth
+96.0%
Year-over-Year

EPIGRAL Income Statement — Revenue, EBITDA & Net Profit

Epigral revenue ₹589 Cr, EBITDA ₹134 Cr, net profit ₹51 Cr, EPS ₹11.87 (2025) — net profit margin 8.7%. Review EPIGRAL P/E ratio to evaluate earnings-based valuation against sector peers.

Periods ₹ Crores
Particulars Sept 2025 Mar 2025 Jun 2025 Dec 2025 Sept 2024 Mar 2024 Jun 2024 Dec 2024 Sept 2023 Mar 2023 Jun 2023 Dec 2023 Sept 2022 Mar 2022 Jun 2022 Dec 2022 Sept 2021 Mar 2021 Jun 2021 Dec 2021
Revenue 589 631 615 603 632 527 654 649 479 567 456 474 557 501 535 538 342 259 291 422
Expenses 455 454 443 494 448 369 475 463 370 408 360 349 375 324 345 371 239 178 198 281
EBITDA 134 177 172 108 185 158 179 187 109 159 97 125 182 177 190 166 103 80 93 141
Operating Profit Margin % 22.00% 28.00% 27.00% 17.00% 29.00% 30.00% 27.00% 28.00% 23.00% 28.00% 21.00% 26.00% 32.00% 35.00% 35.00% 31.00% 30.00% 31.00% 32.00% 33.00%
Depreciation 42 34 42 43 32 30 34 33 32 30 31 31 26 21 22 31 22 21 21 22
Interest 22 12 23 11 27 14 14 0 21 19 18 20 14 12 11 21 10 4 12 10
Profit Before Tax 70 131 107 55 125 113 131 154 56 110 47 74 142 144 156 114 71 55 59 109
Tax 18 44 -54 16 44 36 45 50 18 33 16 25 50 45 49 37 24 22 22 39
Net Profit 51 87 161 39 81 77 86 104 38 77 32 49 92 99 108 77 47 33 37 70
Earnings Per Share (₹) 11.87 20.14 37.25 9.07 19.57 18.60 20.67 24.25 9.14 18.47 7.58 11.81 22.04 23.85 25.94 18.58 11.31 7.89 8.89 16.78

EPIGRAL Balance Sheet — Assets, Liabilities & Shareholders' Equity

EPIGRAL total assets ₹3,152 Cr, total equity ₹1,905 Cr, total liabilities ₹ Cr (2025) — ROE 2.7%.

Years Annual Data ₹ Crores
Particulars 2025 2024 2023 2022 2021
ASSETS
Total Assets 3,152 2,794 2,432 2,124 1,449
Current Assets 775 502 420 447 181
Fixed Assets 2,238 1,767 1,804 1,068 1,102
Capital Work in Progress 64 483 158 589 126
Investments 98 21 21 0 0
Other Assets 752 524 450 467 221
LIABILITIES
Total Liabilities
Current Liabilities 755 761 715 865 376
Non-Current Liabilities
SHAREHOLDERS' EQUITY
Total Equity 1,905 1,254 1,069 726 684
Share Capital 43 42 42 42 253
Reserves & Surplus 1,861 1,213 1,028 684 432

EPIGRAL Cash Flow Statement — Operating, Investing & Financing

Epigral operating cash flow ₹398 Cr, investing ₹-401 Cr, financing ₹-8 Cr, net cash flow ₹-11 Cr (2024).

Periods ₹ Crores
Particulars March 2024 March 2023 March 2022 March 2021
Operating Activities 398 626 284 229
Investing Activities -401 -437 -455 -197
Financing Activities -8 -200 195 -32
Net Cash Flow -11 -11 24 1